# NeuroKaire Brings BrightKaire Antidepressant Blood Test to HLTH 2026 in Las Vegas

> NeuroKaire will demonstrate its BrightKaire blood test at HLTH 2026, ranking antidepressants by patient neuron response.

- Published: 2026-11-15T10:52:46+00:00
- Section: Product Launches
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-15/neurokaire-brightkaire-hlth-2026
- Source: [FinancialContent Business Page](https://www.financialcontent.com/article/gnwcq-2026-11-15-neurokaire-to-showcase-breakthrough-blood-test-that-ends-the-antidepressant-guessing-game-at-hlth-2026-conference)

## Key takeaways

- NeuroKaire will demonstrate its BrightKaire blood test at HLTH 2026, held November 15–18, 2026 at the Venetian Expo in Las Vegas.
- BrightKaire ranks antidepressants by their effect on a patient's own blood-derived neurons, reporting an AUC of 0.81 and 84% positive predictive value.
- The test requires a standard blood draw that can be completed at Quest labs or a provider's office, with results shared through a provider portal.

NeuroKaire will demonstrate its BrightKaire blood test at HLTH 2026, running November 15–18, 2026 at the Venetian Expo in Las Vegas, the company said in a [FinancialContent Business Page](https://www.financialcontent.com/article/gnwcq-2026-11-15-neurokaire-to-showcase-breakthrough-blood-test-that-ends-the-antidepressant-guessing-game-at-hlth-2026-conference) announcement. Company leadership will meet health system leaders, payers, investors and clinical innovators at the event.

## How the BrightKaire Test Works

[NeuroKaire](https://akta.pro/company-profiles/00023hn/neurokaire)'s BrightKaire platform uses a standard blood draw to generate patient-specific functional neurons. A proprietary algorithm then ranks antidepressants by how effective each one is on that patient's neurons, with an AUC of 0.81 and 84% positive predictive value.

The test requires a blood draw that can be completed at Quest labs or a provider's office. Results reach the provider through a portal, where they can be discussed with patients.

"Despite decades of progress, people seeking relief from depression often endure uncertainty as medications are tried and adjusted through guesswork," said Talia Cohen Solal, Ph.D., co-founder and chief executive officer of NeuroKaire. "The BrightKaire test opens a biological window into each patient's brain, bringing precision prescribing into routine care."

HLTH attendees can request a one-on-one briefing or discuss integration opportunities through the contact details in the company's [announcement](https://www.neurokaire.com).

## NeuroKaire's Partnerships and Funding Record

NeuroKaire launched BrightKaire commercially in the United States in September 2025 following CLIA certification, making it available to patients and physicians in 49 of 50 US states, according to akta.pro [company records](https://akta.pro/company-data). The same records show a December 2024 funding round of $10 million led by GreyBird Ventures and a September 2021 Series A of $10 million, also led by GreyBird Ventures.

The records list an October 2025 R&D collaboration with Compass Pathways to study cellular mechanisms of psychedelic compounds on patient-derived neurons for precision depression treatment. A precision medicine collaboration with NeuroSense Therapeutics applies patient-derived neurons and neuronal plasticity markers to Alzheimer's drug development.

## Earlier Steps Toward Precision Prescribing

In July 2026, hybrid mental healthcare provider Mindful Care partnered with NeuroKaire to incorporate the BrightKaire blood test into antidepressant prescribing across six U.S. states, MobiHealthNews reported. In September 2026, CTech reported that NeuroKaire was selected for ScaleUp House's inaugural cohort and that BrightKaire is covered by Medicare and Medicaid, with plans to expand into ADHD and anxiety.

## HLTH 2026 Dates

HLTH 2026 takes place November 15–18, 2026 at the Venetian Expo in Las Vegas.

## Companies in this story

- [NeuroKaire company profile](https://akta.pro/company-profiles/00023hn/neurokaire) · website: https://www.neurokaire.com

---
News for Agent · https://newsforagent.com/llms.txt